Special Issue - Critical Reviews of Immunotheranostics

Guest editors: Xiaoyuan (Shawn) Chen (NIBIB/NIH) and Mingnan Chen (University of Utah)

Editorial
Critical reviews of immunotheranostics
Xiaoyuan Chen, Mingnan Chen
Theranostics 2020; 10(16): 7403-7405. doi:10.7150/thno.48966
[Abstract] [Full text] [PDF]

Small molecules as theranostic agents in cancer immunology
Jindian Li, Juno Van Valkenburgh, Xingfang Hong, Peter S. Conti, Xianzhong Zhang, Kai Chen
Theranostics 2019; 9(25): 7849-7871. doi:10.7150/thno.37218
[Abstract] [Full text] [PDF] [PubMed] [PMC]

STING activation in cancer immunotherapy
Ting Su, Yu Zhang, Kristoffer Valerie, Xiang-Yang Wang, Shuibin Lin, Guizhi Zhu
Theranostics 2019; 9(25): 7759-7771. doi:10.7150/thno.37574
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Peptide-based materials for cancer immunotherapy
Lu Zhang, Yanyu Huang, Aaron Raymond Lindstrom, Tzu-Yin Lin, Kit S Lam, Yuanpei Li
Theranostics 2019; 9(25): 7807-7825. doi:10.7150/thno.37194
[Abstract] [Full text] [PDF] [PubMed] [PMC]

RNA Nanotechnology-Mediated Cancer Immunotherapy
Yao-Xin Lin, Yi Wang, Sara Blake, Mian Yu, Lin Mei, Hao Wang, Jinjun Shi
Theranostics 2020; 10(1): 281-299. doi:10.7150/thno.35568
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Opportunities and Challenges for Antibodies against Intracellular Antigens
Xiaofeng Yang, Shenxia Xie, Xiaomei Yang, Juan C. Cueva, Xiaoqiong Hou, Zhuoran Tang, Hua Yao, Fengzhen Mo, Shihua Yin, Aiqun Liu, Xiaoling Lu
Theranostics 2019; 9(25): 7792-7806. doi:10.7150/thno.35486
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Theranostics in immuno-oncology using nanobody derivatives
Quentin Lecocq, Yannick De Vlaeminck, Heleen Hanssens, Matthias D'Huyvetter, Geert Raes, Cleo Goyvaerts, Marleen Keyaerts, Nick Devoogdt, Karine Breckpot
Theranostics 2019; 9(25): 7772-7791. doi:10.7150/thno.34941
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Advances in Engineering Cells for Cancer Immunotherapy
Xiao Xu, Teng Li, Shiyang Shen, Jinqiang Wang, Peter Abdou, Zhen Gu, Ran Mo
Theranostics 2019; 9(25): 7889-7905. doi:10.7150/thno.38583
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Perspectives on Recent Progress in Focused Ultrasound Immunotherapy
Natasha D. Sheybani, Richard J. Price
Theranostics 2019; 9(25): 7749-7758. doi:10.7150/thno.37131
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Nanoparticle Delivery of Immunostimulatory Agents for Cancer Immunotherapy
Jia Zhuang, Maya Holay, Joon Ho Park, Ronnie H. Fang, Jie Zhang, Liangfang Zhang
Theranostics 2019; 9(25): 7826-7848. doi:10.7150/thno.37216
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Recent advances and challenges of repurposing nanoparticle-based drug delivery systems to enhance cancer immunotherapy
Seungho Lim, Jooho Park, Man Kyu Shim, Wooram Um, Hong Yeol Yoon, Ju Hee Ryu, Dong-Kwon Lim, Kwangmeyung Kim
Theranostics 2019; 9(25): 7906-7923. doi:10.7150/thno.38425
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Modulation of tumor microenvironment for immunotherapy: focus on nanomaterial-based strategies
Yun Liu, Jianfeng Guo, Leaf Huang
Theranostics 2020; 10(7): 3099-3117. doi:10.7150/thno.42998
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Molecular imaging biomarkers for immune checkpoint inhibitor therapy
Pim P van de Donk, Laura Kist de Ruijter, Marjolijn N Lub-de Hooge, Adrienne H Brouwers, Anthonie J van der Wekken, Sjoukje F Oosting, Rudolf SN Fehrmann, Derk Jan A de Groot, Elisabeth GE de Vries
Theranostics 2020; 10(4): 1708-1718. doi:10.7150/thno.38339
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-Oncology
Benjamin B. Kasten, Neha Udayakumar, Jianmei W. Leavenworth, Anna M. Wu, Suzanne E. Lapi, Jonathan E. McConathy, Anna G. Sorace, Asim K. Bag, James M. Markert, Jason M. Warram
Theranostics 2019; 9(17): 5085-5104. doi:10.7150/thno.34415
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Imaging of T-cells and their responses during anti-cancer immunotherapy
Massis Krekorian, Gilbert O. Fruhwirth, Mangala Srinivas, Carl G. Figdor, Sandra Heskamp, Timothy H. Witney, Erik H.J.G. Aarntzen
Theranostics 2019; 9(25): 7924-7947. doi:10.7150/thno.37924
[Abstract] [Full text] [PDF] [PubMed] [PMC]

The yin and yang of imaging tumor associated macrophages with PET and MRI
Sudip Mukherjee, Dominik Sonanini, Andreas Maurer, Heike E. Daldrup-Link
Theranostics 2019; 9(25): 7730-7748. doi:10.7150/thno.37306
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Screening for new macrophage therapeutics
Christopher B. Rodell, Peter D. Koch, Ralph Weissleder
Theranostics 2019; 9(25): 7714-7729. doi:10.7150/thno.34421
[Abstract] [Full text] [PDF] [PubMed] [PMC]

Quantitative Proteomics and Metabolomics Reveal Biomarkers of Disease as Potential Immunotherapy Targets and Indicators of Therapeutic Efficacy
Melanie A. MacMullan, Zachary S. Dunn, Nicolas Graham, Lili Yang, Pin Wang
Theranostics 2019; 9(25): 7872-7888. doi:10.7150/thno.37373
[Abstract] [Full text] [PDF] [PubMed] [PMC]